CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT) - April '19 update

Apr 11, 12:00 PM

CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT), returns to Stock Day to talk in detail about multiple wholly owned divisions, including Skyline Medical, Tumor Genesis, and Helomics.

automated # breast cancer # Cytopatch # D-chip # FDA cleared # Lung cancer # medical devices # Ovvarian # patented # Precision Oncology # STREAMWAY® System # Tumor Genesis # Tumor treatments # waste fluid management